• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Titans with Larry Zeifman of Zeifmans LLP

Microdose by Microdose
December 2, 2021
in Psychedelic Titans
Reading Time: 2 mins read
A A
Psychedelic Titans with Larry Zeifman of Zeifmans LLP

This week’s Psychedelic Titan is Larry Zeifman, Partner of Zeifmans LLP. Zeifmans LLP is a full-service tax, accounting and business consulting firm based in Toronto, Canada, and is ranked as one of Canada’s top 20 firms by revenue.

What’s this article series about? Psychedelic Titans is a get-to-know-you-style blog series interviewing some of the psychedelic industry’s most influential and impactful individuals.

When did you first become involved in the psychedelic industry and why?

As clients started up companies in the space about 2 years ago. I had already been familiar with the space because my son as a psychology doctoral student is a researcher in psychedelics.

Do you, or have you taken, psychedelic substances?

No.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

What’s your favourite psychedelic compound?

I believe psilocybin likely has the best prospects for effective treatment of mental illness.

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Do your parents/family members know what you’re doing?

Buy Lasix Directly Online

My family knows. I am not a user, I am a capitalist.

Have you had an experience with mental health/chronic pain?

Yes, with chronic pain.

What’s your vision of the industry in 20 years?

I anticipate that psychedelics will be in widespread use in treating mental illness.

What are your biggest worries for the industry?

Inconclusive studies.

Who are your heroes?

The guys at Microdose of course!

If you could create a psychedelic to do anything you wanted, what would it do?

Chronic pain is probably the area most in need of a solution.

 

We’d like to thank Larry for being a part of the Psychedelic Titans series. Stay tuned for more profiles on leaders in the psychedelic industry.

Would you like to participate in this series? Fill out this form and we’ll follow up with a review of your application.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Zeifmans
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Breaking News: MAPS and Vine VC Launch Innovative $70 Million Funding Structure

Breaking News: MAPS and Vine VC Launch Innovative $70 Million Funding Structure

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.